SSA
CBPO

Schonfeld Strategic Advisors’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Schonfeld Strategic Advisors’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-9,651
Closed -$986K – 1813
2020
Q2 		$986K Buy
9,651
+7,251
+302% +$776K 0.03% 607
2020
Q1 		$259K Buy
+2,400
New +$276K 0.02% 808
2019
Q3 		– Sell
-54,797
Closed -$5.22M – 1364
2019
Q2 		$5.22M Buy
+54,797
New +$5.16M 0.18% 137

Other funds holding CBPO

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
YCMGA
York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MCP
Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capstone Investment Advisors
Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Schonfeld Strategic Advisors's CBPO Position: Q3 2020 in Review

Schonfeld Strategic Advisors sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2020, closing a stake of 9,651 shares — an estimated $986K sold.

Schonfeld Strategic Advisors first reported a position in CBPO in Q2 2019 and held it in 3 quarters. The position peaked at $5.22M in Q2 2019. 87 funds tracked by Wall St. Rank hold CBPO as of Q3 2020.

  • Schonfeld Strategic Advisors reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2020 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 9,651 China Biologic Products Holdings, Inc. shares in Q3 2020, an estimated $986K.
  • Schonfeld Strategic Advisors first reported a position in China Biologic Products Holdings, Inc. in Q2 2019 and held it in 3 quarters.
  • Schonfeld Strategic Advisors's China Biologic Products Holdings, Inc. position peaked at $5.22M in Q2 2019.
  • 87 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2020.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.